The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Towards precision pain management-the case for targeting DRP1 in remifentanil-induced hyperalgesia

  • Ki Tae Jung (Department of Anesthesiology and Pain Medicine, Chosun University Hospital, School of Medicine and Medical College, Chosun University)
  • Received : 2023.09.06
  • Accepted : 2023.09.09
  • Published : 2023.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006; 104: 570-87. https://doi.org/10.1097/00000542-200603000-00025
  2. Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011; 14: 145-61. https://doi.org/10.36076/ppj.2011/14/145
  3. Cohen SP, Christo PJ, Wang S, Chen L, Stojanovic MP, Shields CH, et al. The effect of opioid dose and treatment duration on the perception of a painful standardized clinical stimulus. Reg Anesth Pain Med 2008; 33: 199-206. https://doi.org/10.1097/00115550-200805000-00002
  4. Lee C, Kim YD, Kim JN. Antihyperalgesic effects of dexmedetomidine on high-dose remifentanil-induced hyperalgesia. Korean J Anesthesiol 2013; 64: 301-7. https://doi.org/10.4097/kjae.2013.64.4.301
  5. Zhou S, Pan Y, Zhang Y, Gu L, Ma L, Xu Q, et al. Antisense oligodeoxynucleotides against dynamin-related protein 1 reduce remifentanil-induced hyperalgesia by modulating spinal N-methyl-D-aspartate receptor expression in rats. Korean J Pain 2023; 36: 316-27. https://doi.org/10.3344/kjp.22398
  6. Gibellini L, Bianchini E, De Biasi S, Nasi M, Cossarizza A, Pinti M. Natural compounds modulating mitochondrial functions. Evid Based Complement Alternat Med 2015; 2015: 527209.
  7. Tsushima K, Bugger H, Wende AR, Soto J, Jenson GA, Tor AR, et al. Mitochondrial reactive oxygen species in lipotoxic hearts induce post-translational modifications of AKAP121, DRP1, and OPA1 that promote mitochondrial fission. Circ Res 2018; 122: 58-73. https://doi.org/10.1161/CIRCRESAHA.117.311307
  8. Atkins K, Dasgupta A, Chen KH, Mewburn J, Archer SL. The role of Drp1 adaptor proteins MiD49 and MiD51 in mitochondrial fission: implications for human disease. Clin Sci (Lond) 2016; 130: 1861-74. https://doi.org/10.1042/CS20160030
  9. Petersen-Felix S, Curatolo M. Neuroplasticity--an important factor in acute and chronic pain. Swiss Med Wkly 2002; 132: 273-8. https://doi.org/10.4414/smw.2002.09913
  10. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000; 288: 1765-9. https://doi.org/10.1126/science.288.5472.1765
  11. Paoletti P, Bellone C, Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 2013; 14: 383-400. https://doi.org/10.1038/nrn3504
  12. Mohan A, Fitzsimmons B, Zhao HT, Jiang Y, Mazur C, Swayze EE, et al. Antisense oligonucleotides selectively suppress target RNA in nociceptive neurons of the pain system and can ameliorate mechanical pain. Pain 2018; 159: 139-49. https://doi.org/10.1097/j.pain.0000000000001074
  13. Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov 2020; 19: 673-94. https://doi.org/10.1038/s41573-020-0075-7